TCA
ASBPW
Taconic Capital Advisors’s Aspire Biopharma Holdings, Inc. Warrant ASBPW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4K | Hold |
300,000
| – | – | ﹤0.01% | 44 |
|
|
2025
Q1 | $20.3K | Hold |
300,000
| – | – | ﹤0.01% | 41 |
|
|
2024
Q4 | $14.3K | Hold |
300,000
| – | – | ﹤0.01% | 47 |
|
|
2024
Q3 | $12.7K | Hold |
300,000
| – | – | ﹤0.01% | 45 |
|
|
2024
Q2 | $9.03K | Hold |
300,000
| – | – | ﹤0.01% | 63 |
|
|
2024
Q1 | $9.03K | Hold |
300,000
| – | – | ﹤0.01% | 72 |
|
|
2023
Q4 | $18K | Hold |
300,000
| – | – | ﹤0.01% | 77 |
|
|
2023
Q3 | $15K | Hold |
300,000
| – | – | ﹤0.01% | 105 |
|
|
2023
Q2 | $15K | Hold |
300,000
| – | – | ﹤0.01% | 156 |
|
|
2023
Q1 | $12.5K | Hold |
300,000
| – | – | ﹤0.01% | 229 |
|
|
2022
Q4 | $24K | Hold |
300,000
| – | – | ﹤0.01% | 361 |
|
|
2022
Q3 | $36K | Hold |
300,000
| – | – | ﹤0.01% | 453 |
|
|
2022
Q2 | $36K | Buy |
+300,000
| New | +$36K | ﹤0.01% | 521 |
|